Ubs Asset Management Americas holds 620,751 shares or 0% of its portfolio. The stock declined 0.09% or $0.05 reaching $57.55 per share. About 276,995 shares traded. Callon Petroleum Company (NYSE:CPE) has risen 12.29% since October 12, 2016 and is uptrending. It has underperformed by 4.41% the S&P500. Short interest grew 9,662,287 over that timeframe. CYTR's SI was 16.41 million shares in October as released by FINRA. Victory Capital stated it has 2.20 million shares or 0.05% of all its holdings. The overall volume in the last trading session was 3.3 million shares. It is 0.02% or $0 reaching $0.409 per share. AT&T Inc. (NYSE:T) has declined 0.52% since October 11, 2016 and is downtrending. It has underperformed by 8.52% the S&P500. Tennessee-based Ftb Advsr Inc has invested 0% in Callon Petroleum Company (NYSE:CPE).
Callon Petroleum Company has a consensus outperform rating from 24 Wall Street analysts, and the number of shares now sold short amount to at least 19.87% of shares outstanding. The rating was maintained by Oppenheimer on Tuesday, August 8 with "Hold".
Analysts expect Callon Petroleum Company (NYSE:CPE) to report $0.12 EPS on November, 1.They anticipate $0.03 EPS change or 33.33% from last quarter's $0.09 EPS. The company was maintained on Tuesday, April 11 by Argus Research. The firm has "Buy" rating by RBC Capital Markets given on Friday, June 2. Sir Cap Mgmt L P has invested 5.41% of its portfolio in Callon Petroleum Company (NYSE:CPE). As per Wednesday, August 2, the company rating was maintained by BMO Capital Markets. Scotiabank set a $15.00 price objective on Callon Petroleum and gave the stock a "buy" rating in a research report on Saturday, July 1st. The rating was maintained by Citigroup on Monday, July 18 with "Neutral".
Brant Point Investment Management Llc decreased Marathon Pete Corp (Call) (NYSE:MPC) stake by 50,000 shares to 51,500 valued at $2.70M in 2017Q2. Qs Investors Ltd Com owns 15,500 shares.
Investors sentiment decreased to 1.73 in 2017 Q2. The general interpretation of the ATR is the higher the ATR value, the higher the volatility. It is negative, as 38 investors sold CPE shares while 55 reduced holdings.
AbbVie (NYSE:ABBV) Gets an Upgrade to a "Market Perform" Rating
The current ratio looks at all the liquid and non-liquid assets compared to the company's total current liabilities. (NYSE:KBR). Principal Gp has invested 0.01% of its portfolio in KBR, Inc. 140,006 were reported by Palladium Prtn Limited Liability.
A number of hedge funds have recently added to or reduced their stakes in CPE. 229.70 million shares or 2.94% more from 223.13 million shares in 2017Q1 were reported. Jefferies Group also issued estimates for Callon Petroleum's Q3 2017 earnings at $0.14 EPS, Q4 2017 earnings at $0.18 EPS, FY2017 earnings at $0.58 EPS, Q1 2018 earnings at $0.14 EPS, Q2 2018 earnings at $0.16 EPS, Q3 2018 earnings at $0.20 EPS, Q4 2018 earnings at $0.22 EPS, FY2018 earnings at $0.72 EPS, Q1 2019 earnings at $0.27 EPS, Q2 2019 earnings at $0.28 EPS, Q3 2019 earnings at $0.30 EPS and FY2019 earnings at $1.17 EPS. Pitcairn stated it has 0.02% in Callon Petroleum Company (NYSE:CPE).
Callon Petroleum Company (NYSE:CPE) in the last month has increased +3.19%. M&T Financial Bank reported 17,407 shares. Schroder Inv Management Group owns 563,187 shares for 0.01% of their portfolio. CPE's profit would be $24.44M giving it 22.81 P/E if the $0.12 EPS is correct. Comerica Bancorporation stated it has 208,092 shares. Raymond James Svcs Advsrs owns 12,498 shares for 0% of their portfolio. Busey Tru invested in 0.48% or 92,719 shares. The institutional investor held 117,180 shares of the department and specialty retail stores company at the end of 2017Q2, valued at $6.13M, down from 126,812 at the end of the previous reported quarter. Days to cover increased 5.0 to 9.0 and the percentage of shorted shares was 0.25% on September 29. The stock of Callon Petroleum Company (NYSE:CPE) has "Overweight" rating given on Friday, August 14 by KeyBanc Capital Markets. 1492 Capital Management Limited Liability Company owns 15,412 shares.
CytRx Corporation is a biopharmaceutical research and development firm specializing in oncology. Channing Cap Ltd holds 2.54M shares. The Firm is focused on the clinical development of aldoxorubicin, its modified version of the chemotherapeutic agent, doxorubicin. It is engaged in Phase III trials for aldoxorubicin as a therapy for patients with soft tissue sarcoma whose tumors have progressed after treatment with chemotherapy. Its up 0.18, from 0.97 in 2017Q1. 41 funds opened positions while 125 raised stakes.
Is Microsoft Corporation (NASDAQ:MSFT) Cheap From Peers? Barclays Plc reported 0% of its portfolio in CytRx Corporation (NASDAQ:CYTR). Bankshares Of Montreal Can has 490 shares for 0% of their portfolio. (NYSE:T). Cutler Inv Counsel Ltd Liability holds 224,048 shares. 5,756 are held by Wells Fargo And Co Mn. Barrow Hanley Mewhinney Strauss Ltd Co holds 0.09% or 5.83 million shares. The New Jersey-based Finance Architects Inc has invested 0% in Middleby Corp (NASDAQ:MIDD).
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.